Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
14.72 NOK | +0.34% | +2.58% | -31.21% |
05-14 | Transcript : Nykode Therapeutics AS, Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | Nykode Therapeutics AS Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
448M | - | |||||
115B | ||||||
107B | ||||||
21.6B | - | |||||
22.31B | - | |||||
19.19B |
- Stock Market
- Equities
- VACC Stock
- Charts Nykode Therapeutics
- Sector Chart